awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46224137-4755B3A8-13F3-4B73-A9F2-1D1E2BAAA102
Q46224137-4755B3A8-13F3-4B73-A9F2-1D1E2BAAA102
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46224137-4755B3A8-13F3-4B73-A9F2-1D1E2BAAA102
Discovery of a COX-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effect.
P2860
Q46224137-4755B3A8-13F3-4B73-A9F2-1D1E2BAAA102
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46224137-4755B3A8-13F3-4B73-A9F2-1D1E2BAAA102
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81b140d4864a651b208dafeb2c236b89f44b50ce
P2860
A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group.